Wu, J. J., Spelman, L., Tan, J. L., Etoh, T., Zhang, H., Shumel, B., & Rossi, A. B. (2021). Dupilumab Maintains Long-Term Disease Control in Adults with Moderate-to-Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial. Dermatol Ther (Heidelb).
シカゴスタイル引用形Wu, Jashin J., Lynda Spelman, Jerry L. Tan, Takafumi Etoh, Haixin Zhang, Brad Shumel, , Ana B. Rossi. "Dupilumab Maintains Long-Term Disease Control in Adults With Moderate-to-Severe Atopic Dermatitis As Measured By Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial." Dermatol Ther (Heidelb) 2021.
MLA引用形式Wu, Jashin J., et al. "Dupilumab Maintains Long-Term Disease Control in Adults With Moderate-to-Severe Atopic Dermatitis As Measured By Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial." Dermatol Ther (Heidelb) 2021.